NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,880,998 | -0.6% | 303,171 | -1.5% | 1.42% | +1.2% |
| Q2 2023 | $31,072,308 | +8.8% | 307,921 | -0.8% | 1.41% | +3.2% |
| Q1 2023 | $28,567,288 | +100549.3% | 310,514 | -0.8% | 1.36% | +7.2% |
| Q4 2022 | $28,383 | -99.9% | 312,864 | +8.3% | 1.27% | +22.0% |
| Q3 2022 | $21,953,000 | -10.8% | 288,818 | -0.8% | 1.04% | -3.4% |
| Q2 2022 | $24,617,000 | +0.5% | 291,222 | +4.4% | 1.08% | +25.6% |
| Q1 2022 | $24,488,000 | +2.6% | 279,064 | +2.2% | 0.86% | +11.4% |
| Q4 2021 | $23,877,000 | -50.0% | 272,978 | -53.3% | 0.77% | -20.2% |
| Q3 2021 | $47,770,000 | +372.1% | 584,124 | +426.7% | 0.96% | +153.3% |
| Q2 2021 | $10,118,000 | +9.7% | 110,893 | +2.8% | 0.38% | +1.1% |
| Q1 2021 | $9,224,000 | -7.8% | 107,901 | +1.9% | 0.38% | -20.5% |
| Q4 2020 | $9,999,000 | +10.9% | 105,882 | +2.1% | 0.47% | +1.9% |
| Q3 2020 | $9,017,000 | +4.0% | 103,689 | +0.6% | 0.46% | +2.2% |
| Q2 2020 | $8,674,000 | +4.6% | 103,074 | +2.4% | 0.46% | -20.2% |
| Q1 2020 | $8,296,000 | -11.5% | 100,619 | +1.6% | 0.57% | +14.9% |
| Q4 2019 | $9,377,000 | +11.0% | 99,022 | +1.9% | 0.50% | +1.2% |
| Q3 2019 | $8,447,000 | -4.8% | 97,206 | +0.0% | 0.49% | -4.9% |
| Q2 2019 | $8,873,000 | -24.6% | 97,181 | -20.6% | 0.52% | -26.7% |
| Q1 2019 | $11,761,000 | +16.1% | 122,328 | +3.6% | 0.70% | +0.7% |
| Q4 2018 | $10,129,000 | +8.3% | 118,039 | +8.7% | 0.70% | +29.5% |
| Q3 2018 | $9,353,000 | +10.1% | 108,553 | -3.4% | 0.54% | +2.3% |
| Q2 2018 | $8,492,000 | -8.7% | 112,418 | -2.3% | 0.53% | -11.3% |
| Q1 2018 | $9,306,000 | -1.7% | 115,095 | +2.1% | 0.59% | -0.7% |
| Q4 2017 | $9,467,000 | -5.1% | 112,759 | -3.0% | 0.60% | -10.6% |
| Q3 2017 | $9,976,000 | +11.7% | 116,206 | +8.6% | 0.67% | +8.6% |
| Q2 2017 | $8,928,000 | +118.4% | 106,959 | +94.4% | 0.62% | +127.3% |
| Q1 2017 | $4,087,000 | -17.1% | 55,018 | -18.8% | 0.27% | -21.9% |
| Q4 2016 | $4,932,000 | -73.0% | 67,716 | -70.8% | 0.35% | -74.1% |
| Q3 2016 | $18,287,000 | -0.9% | 231,605 | +3.5% | 1.34% | -5.3% |
| Q2 2016 | $18,460,000 | +101.6% | 223,721 | +76.9% | 1.41% | +87.9% |
| Q1 2016 | $9,159,000 | -18.7% | 126,432 | -3.4% | 0.75% | -18.4% |
| Q4 2015 | $11,261,000 | -8.1% | 130,888 | -1.8% | 0.92% | -14.2% |
| Q3 2015 | $12,256,000 | +912.1% | 133,339 | +983.3% | 1.07% | +974.0% |
| Q2 2015 | $1,211,000 | -28.8% | 12,309 | -28.6% | 0.10% | -30.1% |
| Q1 2015 | $1,701,000 | +3.4% | 17,245 | -2.8% | 0.14% | 0.0% |
| Q4 2014 | $1,645,000 | -2.3% | 17,746 | -0.9% | 0.14% | -4.7% |
| Q3 2014 | $1,684,000 | +3.3% | 17,899 | -0.6% | 0.15% | +6.4% |
| Q2 2014 | $1,630,000 | +4.0% | 18,002 | -2.3% | 0.14% | -2.1% |
| Q1 2014 | $1,567,000 | +4.5% | 18,422 | -1.2% | 0.14% | +3.6% |
| Q4 2013 | $1,499,000 | +4.1% | 18,645 | -0.7% | 0.14% | -2.8% |
| Q3 2013 | $1,440,000 | +5.8% | 18,775 | -2.5% | 0.14% | +1.4% |
| Q2 2013 | $1,361,000 | – | 19,255 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |